Get in Touch
0
0
We Serve

Clinical Diagnostics

Discover how our data-driven solutions have helped stakeholders in Precision Medicine drive growth and stay ahead of the curve
What we do

Select Capabilities

All Capabilities

Revenue Projection

No one can predict the future, but with the right research and analysis, you can understand the different market scenarios you may face. DeciBio takes a data-driven approach, considering customer demand and preference, product profile, competitive dynamics, regulation, and other market factors to inform your potential revenue scenarios.
View

Pricing Strategy

Precise pricing is critical to realizing maximum adoption and market value. DeciBio takes a multi-pronged approach to triangulate optimal price points for your products and services.
View

Target Identification

The right move at the right time can be transformational. In life sciences, the best opportunities lie at the intersection of technology, market, team, and timing. DeciBio can filter the signal from the noise, and identify the best investment targets for your company or fund.
View
Impact

Selected Work

All Work
Clinical Diagnostics
RNA-based Oncology Biomarker Market Landscape
A cancer diagnostics company wanted to understand the current and future landscape for RNA-based oncology biomarkers, focusing on gene expression profiling (GEP) and rearrangements across medical settings
View
Voice-of-Customer Research
Competitive Analysis
Biomarker and Diagnostics Strategy
Product Specification Mapping
Clinical Diagnostics
Opportunity Assessment & Target Customer Identification for In-House Hereditary Cancer Testing
A leader in research and clinical sequencing wanted to assess the market opportunity and key customer segments for an in-house hereditary cancer testing (HCT) solution
View
Customer Segmentation
Voice-of-Customer Research
Market Landscaping and Sizing
Clinical Diagnostics
NIPT Market Landscape and Strategy
A large multi-national diagnostic company was interested in understanding the market landscape and potential strategy for the decentralization of NIPT in the U.S.
View
Voice-of-Customer Research
Competitive Analysis
Customer Segmentation
Go-to-Market Strategy

Featured Team

David Cavanaugh

Founding Partner

Andrew Aijian

Partner

Katie Maloney

Partner

Tina Wang

Senior Project Leader
Data & Platforms

Data & Platforms

See all

Spatial Biology Market Report - Third Edition: 2025-2030

This report provides a summary of the current spatial biology market landscape, as well as a forward-looking perspective of the spatial biology market from 2025 to 2030.
Read More

Advanced & Next-Gen Proteomics Ad Board

DeciBio conducted 11 interviews with academic researchers and biopharma executives to explore how advanced and next-generation proteomics tools have been adopted into research efforts today and how stakeholders expect their use of these tools to change in 2025
Read More

Single Cell Analysis Market Report Sixth Edition, 2024-2029

The sixth edition of this report takes a completely updated and comprehensive look at the SCA market. We assess the SCA market across 6 segments and 31 subsegments.
Read More

Next Generation Sequencing (NGS) Market Assessment Trends (2021-2027)

Next Generation Sequencing (NGS)*, having experienced significant stagnation from 2022 to 2024, is poised for a resurgence. We forecast that the ~$6.4B WW NGS manufacturer market (2024) will grow 9% p.a. to reach $8.3B in 2027.
Read More
Insights Blog

Related Insights

See all

Venture Capital in Europe: A Conversation with Liliane Chamas and Lauren Laing

Read More

Inflection Points of Artificial Intelligence in Drug Development White Paper

Read More

Next-Generation Therapeutics | April Round-Up 2025

Read More

Digital Health and Informatics | March Round-Up 2025

Read More
Precision Medicine is evolving at a rapid pace

Discover how we can help

Get in Touch
© DeciBio 2023 | All rights reserved
Privacy
Terms & Conditions